Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. Regeneron's stock could soar by 50% in the next year from ...

Wolf, Greenfield & Sacks, P.C. is pleased to announce the promotion of Stuart V.C. Duncan Smith, Anant K. Saraswat, Jessica A. von Reyn, and Adam R. Wichman, PhD to the position of shareholder, ...